Delivery Order SPE2DB20D1109-SPE2DB25FP24Z
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at approximately $41K to AmerisourceBergen Drug Corp for the supply of Tivicay 50 mg tablets (30-count units) under a firm fixed price contract type. This award, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a competitive procurement with no set-aside designation. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $5,185.47 to AmerisourceBergen Drug Corp for 30 tablets of Tivicay 50 mg on July 24, 2025, with completion expected by July 25, 2025. This competitively awarded, firm fixed-price contract represents a pharmaceutical supply delivery with no set-aside designation. The vendor, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Tivicay 50 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $4,178.97. This delivery order represents a non-set-aside award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle valued through December 2026. The place of performance is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,002.96 to AmerisourceBergen Drug Corp for the supply of Tivicay 50 mg tablets (30-count packaging). This competitively awarded, firm fixed-price delivery order was executed on June 9, 2025, with an ultimate completion date of June 10, 2025. The contract does not include a set-aside designation. Performance will be fulfilled from AmerisourceBergen Drug Corp's Conshohocken, Pennsylvania facility, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $10,302.29 to AmerisourceBergen Drug Corp for the supply of Tivicay 50 mg tablets (30-count unit) on August 26, 2025, with ultimate completion by August 27, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Tivicay 50 mg tablets in quantities of 30, with a contract ceiling value of $23,342.52. This firm fixed-price delivery order, which is expected to be completed by August 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,015.64 to AmerisourceBergen Drug Corp for the supply of Tivicay 50 mg tablets (30-count units) with a firm fixed price structure. This non-competitive delivery order was executed on September 10, 2025, with an ultimate completion date of September 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled the order from its corporate office location. The...
- The Defense Logistics Agency awarded a delivery order valued at $6,928.84 to AmerisourceBergen Drug Corp for Tivicay 50 mg tablets (30-count packages) on August 27, 2025, with completion scheduled for August 28, 2025. This competitively awarded, firm fixed-price delivery order represents a single-item pharmaceutical procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this requirement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30 tablets of Tivicay 50 mg with a ceiling value of $1,334.31 under a firm fixed price contract type. This award, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation, and performance...
- The Defense Logistics Agency awarded a $4,002.93 delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Tivicay 50 mg tablets (30-count packaging). This competitive award, with no set-aside designation, is a firm fixed-price contract that will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 17, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP24ZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tivicay 50 mg tablets (30-count units) under a firm fixed-price contract structure. The award, issued on June 17, 2025, carries a ceiling value of $6,361.40 and requires completion by June 18, 2025. AmerisourceBergen will perform this work from its corporate office in Conshohocken, Pennsylvania. This is a non-set-aside award issued through open competition, reflecting the contractor's established capability to meet federal pharmaceutical procurement requirements. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with a demonstrated portfolio of competitively awarded contracts across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 6/17/25 |